Diagnostic composition comprising a binuclear complex, its method of preparation and its use in magnetic resonance imaging
AssigneeGuerbet
InventorsCorinne Bourgouin, Gerard Desplanches, Michele Lecayon
Life of this patent
Estimating the term…
Abstract
A diagnostic composition comprising a binuclear complex between a polyaminopolycarboxylic ligand, such as diethylene triamine pentacetic acid, a paramagnetic metal such as Gd and an endogenous metal such as Ca, optionally mixed with the mononuclear complex of the same paramagnetic metal and the same ligand. This composition can be used as a contrasting agent in magnetic resonance imaging.
Claims2
A process for preparing a MRI composition including, (i) a mononuclear complex of diethylene triamine pentaacetic acid (DTPA) with gadolinium ion (Gd.sup.3+), and (ii) a binuclear complex of DTPA with Gd.sup.3+ and an endogenous metal ion which is Ca.sup.2+, comprising the steps of:
- (a) preparing the mononuclear complex Gd-DTPA by reacting DTPA with Gd.sub.2 O.sub.3 ;
- (b) preparing the binuclear complex Ca Gd-DTPA by reacting the mononuclear complex obtained in step (a) with CaCO.sub.3 ;
- (c) combining selected amounts of the mononuclear complex with the binuclear complex in an aqueous solution;
- and
- (d) neutralizing the solution obtained in step (c) with an organic base selected from the group consisting of a basic aminoacid and N-methylglucamine.
A process for preparing a MRI composition including (i) a mononuclear complex of diethylene triamine pentaacetic acid (DTPA) with gadolinium ion (Gd.sup.3+), and (ii) a binuclear complex of DTPA with Gd.sup.3+ and an endogenous metal ion which is Ca.sup.2+, comprising the steps of:
- (a) preparing the mononuclear complex Gd-DTPA by reacting DTPA with Gd.sub.2 O.sub.3 ;
- (b) preparing the binuclear complex Ca Gd-DTPA by reacting the mononuclear complex obtained in step (a) with CaCo.sub.3 ;
- (c) combining, at a molar ratio of 0.1 to 1, the mononuclear complex with the binuclear complex in an aqueous solution;
- and
- (d) neutralizing the solution obtained in step (c) with an organic base selected from the group consisting of a basic aminoacid and N-methylglucamine.
Dependencies are inferred from the claim text.